Figure 6.
Meloxicam plasmatic concentration in rats following the administration of an (m)PEG–PTMC-based suspension formulation with either a triblock or a diblock copolymer.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.